EyePoint · 21 hours ago
Coop Formulation Development
US-MA-Watertown
Full-time
Onsite
New Grad
$32/hr - $42/hrEyePoint is an ophthalmology company committed to improving the lives of patients with serious retinal diseases. The Co-op will assist in developing ocular formulations and manufacturing processes for pre-clinical and clinical use, while maintaining compliance with safety and regulations.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Develop ocular formulations and manufacturing process for pre-clinical and clinical use
Interpret complicated data sets and provide sound recommendations
Maintain knowledge with up-to-date scientific literature in the field of ocular drug delivery
Maintain a detailed and organized laboratory notebook
Share findings in technical presentations and technical report
Build expertise and knowledge around ocular formulation drug products
Ensure compliance with safety and regulations as well as experimental/laboratory best practices
Qualification
Required
Currently enrolled in a university, pursuing a graduate degree in Pharmaceutical Sciences, Chemical Engineering, Chemistry, or related discipline
Excellent team player with strong interpersonal, written and verbal communication skills
Personal Qualities: Bright, energetic, hard-working, and creative
Preferred
Prior formulation development & characterization experience is a plus
Laboratory research experience (particularly formulations) is a plus (academic or industry)
Company
EyePoint
EyePoint (Nasdaq: EYPT) is a clinical-stage biopharmaceutical company committed to developing and commercializing innovative therapeutics to improve the lives of people with serious retinal diseases.
Founded in 1987
51-200 employees
H1B Sponsorship
EyePoint has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2024 (4)
2021 (1)
Funding
Current Stage
Public CompanyTotal Funding
$803.8MKey Investors
Silicon Valley BankOcumension TherapeuticsEssex Woodlands Healthcare Partners
2025-10-14Post Ipo Equity· $150M
2023-12-05Post Ipo Equity· $215.9M
2022-03-09Post Ipo Debt· $45M
Leadership Team
Paul Ashton
President, Chief Executive Officer and a Director
D
Diane Shay
Vice President of Quality
Recent News
Clinical Trials Arena
2026-01-11
2025-12-17
2025-12-16
Company data provided by crunchbase